First Horizon Corporation’s iShares Biotechnology ETF IBB Stock Holding History

First Horizon Corporation’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Sell	1,217 -825	-40%	-$142K	0.01%	406
2026 Q1	$345K	Buy	2,042 +182	+10%	+$31.1K	0.01%	339
2025 Q4	$314K	Sell	1,860 -5	-0.3%	-$812	0.01%	354
2025 Q3	$269K	Buy	+1,865	New	+$255K	0.01%	340
2021 Q2	$31K	Buy	192 +120	+167%	+$18.5K	﹤0.01%	468
2021 Q1	$10K	Hold	72	–	–	﹤0.01%	679
2020 Q4	$10K	Hold	72	–	–	﹤0.01%	648
2020 Q3	$9K	Buy	+72	New	+$9.77K	﹤0.01%	639

Other funds holding IBB

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

AFG

Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return

GIC

Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return

IHL

Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

First Horizon Corporation's IBB Position: Q2 2026 in Review

First Horizon Corporation reduced its iShares Biotechnology ETF (IBB) stake by 40% in Q2 2026, selling an estimated $142K and leaving 1,217 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #406.

First Horizon Corporation first reported a position in IBB in Q3 2020 and has held it in 8 quarters since. The position peaked at $345K in Q1 2026. 451 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

First Horizon Corporation held 1,217 shares of iShares Biotechnology ETF worth $231K as of Q2 2026.
First Horizon Corporation sold 825 iShares Biotechnology ETF shares in Q2 2026, an estimated $142K.
iShares Biotechnology ETF made up 0.01% of First Horizon Corporation's portfolio in Q2 2026, its #406 holding.
First Horizon Corporation first reported a position in iShares Biotechnology ETF in Q3 2020 and has held it in 8 quarters since.
First Horizon Corporation's iShares Biotechnology ETF position peaked at $345K in Q1 2026.
451 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.